Precursor Cell Lymphoblastic Leukemia-Lymphoma: all 2,121 studies
Page 11 of 22. Open to participants first (492), then studies with results posted, then the rest; newest registration first within each.
- HEM-iSMART-A: Decitabine / Venetoclax and Navitoclax in Pediatric Patients With Relapsed or Refractory Hematological MalignanciesWithdrawnNCT05740449Phase 1/2
- Dose Escalation/Dose Expansion Study of PRGN-3007 UltraCAR-T Cells in Patients With Advanced Hematologic and Solid Tumor MalignanciesCompletedNCT05694364Phase 1
- How Effective is the Dose-graded Aerobic Training in Children Survivors of Acute Lymphoblastic Leukemia?CompletedNCT05679817Not applicable
- Efficacy of Osteopathic Treatment on the Side Effects of Curative Treatments of Lymphoblastic Leukemia in PediatricsStatus unknownNCT05664230
- QPlus Pediatric Reference IntervalTerminatedNCT05645133
- Management of FI After Surgery of ARMCompletedNCT05621629
- CD19 CAR T-cell Target Relapsed/Refractory Acute B Cell Leukemia/LymphomaWithdrawnNCT05613348Phase 1/2
- N-Acetylcysteine vs Placebo as Adjunctive Treatment in Pediatric LeukemiaTerminatedNCT05611086Phase 4
- Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or LymphomaActive, not recruitingNCT05602194Phase 3
- Olverembatinib Combined With Reduced-Intensity Chemotherapy and Venetoclax for de Novo Ph+ ALLCompletedNCT05594784Phase 2
- A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic MalignanciesActive, not recruitingNCT05589896Phase 1/2
- Behavioral Parenting Skills As A Novel Target for Improving Pediatric Medication AdherenceCompletedNCT05587582
- Cladribine Combined With G-CSF and Cytarabine as a Salvage Treatment in R/R ALLStatus unknownNCT05578378Phase 2/3
- Anti-CD19 Universal CAR-T Cells for r/r CD19+ B-ALLWithdrawnNCT05571540Phase 1/2
- Anti-CD19 CAR-Engineered NK Cells in the Treatment of Relapsed/Refractory Acute Lymphoblastic LeukemiaCompletedNCT05563545Phase 1
- Reduced-dose Chemotherapy Followed by Blinatumomab in Induction Therapy of Newly Diagnosed Non-elderly Ph-B-ALLCompletedNCT05557110Phase 2
- Chimeric Antigen Receptor T-Cell (CAR-T) Cells in Patients With R/R T-LBLStatus unknownNCT05554575Phase 1
- A Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute LeukemiasWithdrawnNCT05521087Phase 1
- STI-6129 CD38 ADC for the Treatment of Patients With Relapsed or Refractory Systemic ALL AmyloidosisWithdrawnNCT05519527Phase 1
- Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibitor at Patients With HemoblastosisActive, not recruitingNCT05515029Phase 3
- Novel CAR-T Cell Therapy in the Treatment of Hematopoietic and Lymphoid MalignanciesWithdrawnNCT05513612Phase 1
- Improving Nighttime Access to Care and Treatment; Part 2- GhanaCompletedNCT05506683Not applicable
- RISE With ResidentsCompletedNCT05490121Not applicable
- Donor-Derived CD5 CAR T (CT125B) Cells for Relapsed or Refractory T- Cell Acute Lymphoblastic Leukemia/LymphomaWithdrawnNCT05487495Phase 1
- Characterizing Sleep Among Long-term Survivors of Childhood CancerActive, not recruitingNCT05480904
- Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic LeukemiaStatus unknownNCT05480501Early Phase 1
- A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Naïve Undergoing Surgery to Reduce Postoperative Opioid Use (GAMING-ON Study)CompletedNCT05466994Phase 2
- Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic SyndromeActive, not recruitingNCT05457556Phase 3
- Efficacy and Safety of Inotuzumab Ozogamicin in Treating Adult Patients With Ph Negative ALL With Minimal Residual Disease Positive After Induction ChemotherapyActive, not recruitingNCT05456698Phase 2
- Information Support Using an Online Learning Platform for Malaysian Pediatric Leukemia and Lymphoma ParentsCompletedNCT05455268Not applicable
- CAR-Multicenter Analysis (CAR-MA): Retrospective Study to Characterize CAR T-cell Outcomes and Related Toxicities in Children and Young Adults With B-ALLCompletedNCT05440409
- Study of Azacitidine，Venetoclax，and Flumatinib in Newly Diagnosed Ph-positive Acute Leukemia and CML-AP/BP PatientsCompletedNCT05433532Phase 2
- A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer SurvivorsActive, not recruitingNCT05428176Not applicable
- Expression of Programmed Death-1 (PD-1) & Programmed Death Ligand-1 (PDL-1) in Acute Lymphoblastic Leukemia in PediatricStatus unknownNCT05428111Not applicable
- Family-Based Behavioral Treatment for Childhood Survivors of Acute Lymphoblastic LeukemiaTerminatedNCT05410574Not applicable
- Anti-CD19 CAR-Engineered NK Cells in the Treatment of Relapsed/Refractory B-cell MalignanciesWithdrawnNCT05410041Phase 1
- Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in CancerSuspendedNCT05400122Phase 1
- Study of PIT565 in Relapsed and/or Refractory B-cell MalignanciesActive, not recruitingNCT05397496Phase 1
- A Study of Venetoclax in Combination With Chemotherapy to Treat Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)Active, not recruitingNCT05386576Early Phase 1
- Adding Itacitinib to Cyclophosphamide and Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Hematopoietic Stem Cell TransplantsActive, not recruitingNCT05364762Phase 2
- CAR T Cells Real World Evidence Study Based on the French Hospital Claims Data Source (PMSI)CompletedNCT05349201
- First-in-Human (FIH) Trial of 1A46 in Subjects with Advanced CD20 And/or CD19 Positive B-cell Hematologic MalignanciesTerminatedNCT05348889Phase 1/2
- Effect of Metformin on ABCB1 and AMPK Expression in Adolescents With Newly Diagnosed Acute Lymphoblastic LeukemiaStatus unknownNCT05326984Not applicable
- A Study of Revumenib in Combination With Chemotherapy in Participants With R/R Acute LeukemiaCompletedNCT05326516Phase 1
- Safety Trial of STING-dependent Activators and Stimulated Dendritic Cells for Aggressive Relapsed/Refractory LeukemiasWithdrawnNCT05321940Phase 1
- A Study of the Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to TreatWithdrawnNCT05320380Phase 1/2
- Ponatinib Plus Chemotherapy in Acute Lymphoblastic Leukemia PatientsActive, not recruitingNCT05306301Phase 2
- PRotein Optimization With eXercise to Improve MUscle Mass and Functional outcomeSCompletedNCT05296096Not applicable
- A Triple-targeted Cell Preparation Targeting CD19/CD20/CD22 in Patients With Relapsed/Refractory B-cell Acute Lymphocytic LeukemiaTerminatedNCT05292898Phase 1
- Pyronaridine in Acute Myeloid Leukemia (AML)SuspendedNCT05291390Phase 2
- Anti-CD7 CAR-T Cell Therapy for Relapse and Refractory CD7 Positive T Cell MalignanciesCompletedNCT05290155Phase 1
- Robot Rehab: AAI With Robot During Inpatient Pediatric RehabCompletedNCT05275543Not applicable
- A Phase II Study of the Combination of Ponatinib With Mini-hyper CVD Chemotherapy and Venetoclax in Patients With Relapsed or Refractory T-cell Acute Lymphoblastic LeukemiaTerminatedNCT05268003Phase 2
- Safety and Efficacy of CD19/CD22 Dual Targeted CAR-T Cell Therapy in R/R B-Cell Acute Lymphoblastic LeukemiaStatus unknownNCT05225831Early Phase 1
- To Evaluate the Safety and Tolerability of Human CD19-CD22 Targeted T Cells Injection for Subjects With R/R B-ALL.Status unknownNCT05223686Phase 1
- Expanded Access Program of Venetoclax and Navitoclax for Pediatric Patients with Relapsed or Refractory ALL or LLNo longer availableNCT05215405
- CD7 CAR-T Cell Treatment of Relapsed/Refractory CD7+ T -Acute Lymphoblastic Leukemia/ LymphomaStatus unknownNCT05212584Phase 1
- A Dose Escalation Study of Intensity Modulated Total Marrow Irradiation (IMRT-TMI) Followed by Fludarabine as a Myeloablative Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed and Refractory Hematologic MalignanciesWithdrawnNCT05201183Phase 1/2
- Venetoclax in Addition to Blinatumomab in Adult Patients With Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL)Active, not recruitingNCT05182385Phase 1/2
- Gastric Content Ultrasound Monitoring Prior to Extubation in Critically Ill ChildrenTerminatedNCT05181904
- Cryopreserved MMUD BM With PTCy for Hematologic MalignanciesWithdrawnNCT05170828Phase 1
- CD19- and CD22-directed CAR-T Cell Therapy in Patients With Acute Lymphoblastic LeukemiaWithdrawnNCT05168748Phase 1
- Allogeneic CD19 CAR-T Cells for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic LeukemiaStatus unknownNCT05164042Phase 1/2
- Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic MalignancyStatus unknownNCT05154474
- Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLLTerminatedNCT05153330Phase 1
- Muscle Dysfunction in Patients With Haematological DiseasesActive, not recruitingNCT05150561
- 90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic SyndromeActive, not recruitingNCT05139004Phase 1
- Efficacy of the Use of Bortezomib for the Treatment of Relapsed Leukemia or Positive MRDStatus unknownNCT05137860Phase 4
- Effect of Simvastatin on Sepsis and Febrile Neutropenia in Patients With Acute Lymphoblastic LeukemiaStatus unknownNCT05133310Phase 4
- CAR T Cell Therapy Related Cardiovascular OutcomesCompletedNCT05130489
- Safety and Efficacy of ThisCART7 in Patients With Refractory or Relapsed T Cell MalignanciesStatus unknownNCT05127135Phase 1
- Developpement of 3T MRI ProtocolCompletedNCT05090956Not applicable
- Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCTStatus unknownNCT05066958Phase 1/2
- Evaluating the Feasibility of a Digital Health Coaching Program for Individuals Following CAR T TherapyCompletedNCT05064787Not applicable
- Impact of Cross-training on Induction Treatment Response in Acute Lymphoblastic Leukemia AdultsStatus unknownNCT05059847Not applicable
- PTNS and PFR in the Treatment of Childhood ConstipationCompletedNCT05059756Not applicable
- Safety and Efficacy of Curcumin in Children With Acute Lymphoblastic LeukemiaCompletedNCT05045443Phase 2
- Duvelisib Following Chimeric Antigen Receptor T-Cell TherapyActive, not recruitingNCT05044039Phase 1
- XmAb18968 (CD3-CD38) in Relapsed or Refractory Acute Leukemia and T Cell Lymphoblastic LeukemiaTerminatedNCT05038644Phase 1
- Programmed Allogeneic CRISPR-edited T Cells Engineered to Express Anti-CD19 Chimeric Antigen Receptor (PACE CART19) in Patients With Relapsed Or Refractory CD19+ Leukemia and LymphomaWithdrawnNCT05037669Phase 1
- EFFECT OF TREADMILL TRAINING ON BALANCE AFTER CHEMOTHERAPY IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIACompletedNCT05032716Not applicable
- Donor-Derived CD5 CAR T Cells in Subjects with Relapsed or Refractory T-Cell Acute Lymphoblastic LeukemiaTerminatedNCT05032599Phase 1
- A Study of Dasatinib Plus Reduced Intensive Consolidation Chemotherapy in Ph+ Adult ALLStatus unknownNCT05026229Not applicable
- A Study of TKI Maintenance Therapy Following Allo-HSCT in Newly Diagnosed Ph+ Adult ALLStatus unknownNCT05024357Not applicable
- Assessing the Ontogeny of P-glycoprotein Expression in Blood of Pediatric Leukemic PatientsCompletedNCT05021159
- HCL Single Arm Pilot Study in Treatment of Hyperglycemia of Pediatric ALLTerminatedNCT05006040Early Phase 1
- Palbociclib in Combo w/Chemotherapy in Peds Relapsed/Refractory Acute Lymphoblastic LeukemiaCompletedNCT04996160Phase 1
- A Phase 1 Study of of Anti-CD7 Allogeneic CAR-T Cell Therapy (WU-CART-007) in Patients With Relapsed or Refractory T-ALL/LBLCompletedNCT04984356Phase 1
- Anti-Covid-19 Vaccine in Children With Acute Leukemia and Their SiblingsCompletedNCT04969601Phase 1/2
- Oral Health Condition and Quality of Life in Children With LeukemiaTerminatedNCT04968860
- The Effectiveness of the Training Given With Audio and Picture Book Before the SurgeryWithdrawnNCT04960761Not applicable
- JZP458 - Recombinant Erwinia Asparaginase for Treatment of ALL / LBL Patients With Hypersensitivity to E. Coli-derived AsparaginaseApproved for marketingNCT04943952
- Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe)CompletedNCT04942730Phase 2
- Pediatric VaccinationsCompletedNCT04936776
- Non-gene Edited Anti-CD7 CAR T Cells for Relapsed/Refractory T Cell MalignancesStatus unknownNCT04934774Phase 1
- Financial Distress During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United StatesActive, not recruitingNCT04928599
- Clinical Study of SenL-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic LymphomaStatus unknownNCT04916860Not applicable
- Validation of the ANI in Perpubescent Patients in Pediatric Intensive Care Unit.CompletedNCT04913038
- HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation CyclophosphamideActive, not recruitingNCT04904588Phase 2
- Phase I Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and AdolescentsCompletedNCT04888468Phase 1